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Cytoplasmic transport and localization of mRNA has
been reported for a range of oocytes and somatic cells.
The heterogeneous nuclear ribonucleoprotein (hnRNP)
A2 response element (A2RE) is a 21-nucleotide segment
of the myelin basic protein mRNA that is necessary and
sufficient for cytoplasmic transport of this message in
oligodendrocytes. The predominant A2RE-binding pro-
tein in rat brain has previously been identified as
hnRNP A2. Here we report that an 11-nucleotide subseg-
ment of the A2RE (A2RE11) was as effective as the full-
length A2RE in binding hnRNP A2 and mediating trans-
port of heterologous RNA in oligodendrocytes. Point
mutations of the A2RE11 that eliminated binding to
hnRNP A2 also markedly reduced the ability of these
oligoribonucleotides to support RNA transport. Oligo-
dendrocytes treated with antisense oligonucleotides di-
rected against the translation start site of hnRNP A2
had reduced levels of this protein and disrupted trans-
port of microinjected myelin basic protein RNA. Several
A2RE-like sequences from localized neuronal RNAs also
bound hnRNP A2 and promoted RNA transport in oligo-
dendrocytes. These data demonstrate the specificity of
A2RE recognition by hnRNP A2, provide direct evidence
for the involvement of hnRNP A2 in cytoplasmic RNA
transport, and suggest that this protein may interact
with a wide variety of localized messages that possess
A2RE-like sequences.
Vectorial transport and localized translation of mRNA in the
cytoplasm affords a mechanism for establishing an asymmetric
distribution of cytosolic proteins in cells. This is particularly
important in oogenesis and embryonic development (1–8). In
somatic cells, some mRNAs are also transported to discrete
locations within the cell. These include myelin basic protein
(MBP)1 mRNA, which is localized in the myelinating periphery
of oligodendrocytes (9–11), microtubule-associated protein 2A
(MAP2A) and tau, which are localized in neurites (12–14), and
!-actin mRNA, which is localized in the leading edge of fibro-
blasts (15–17).
An active, multistep, cytoplasmic transport pathway has
been delineated for MBP mRNA in cultured oligodendrocytes.
MBP transcripts microinjected into the soma assemble into
granules that move out along the myelin-forming processes (18,
19). Transport of these granules is dependent on the presence
of kinesin and intact microtubules (20). Similar RNA-rich gran-
ules have been observed in other cells (21–24).
A cis-acting sequence sufficient and necessary for MBP
mRNA transport has been identified within a 21-nucleotide
stretch of the 3!-untranslated region. Incorporation of this seg-
ment, the hnRNP A2 response element (A2RE, formerly
termed the RNA transport sequence (25)), into heterologous
RNAs mediates transport into the processes and also enhances
translation.2 A2RE-like sequences are present in other local-
ized mRNAs including mouse MAP2A, mouse protamine 2, and
rat glial fibrillary acidic protein (25), suggesting that the A2RE
represents a general signal for RNA transport.
Earlier we used biotin-labeled oligoribonucleotides contain-
ing the A2RE to isolate proteins that bind specifically to this
RNA sequence (26). Affinity matrices were created by attaching
these oligoribonucleotides to streptavidin-labeled magnetic
particles, which were added to subcellular protein fractions
prepared from a variety of rat tissues. The principal proteins
bound to immobilized A2RE, but not to randomized sequences,
were hnRNP A2 (26) and two isomers of hnRNP A3.3 Subse-
quent binding experiments with purified protein showed that
hnRNP A3 had little affinity for A2RE in the absence of hnRNP
A2 (26).
The initial aim of the work communicated here was to define
the nucleotides within the A2RE that are essential for binding
to hnRNP A2 and to determine if other nonoligodendroglial,
localized messages that possess A2RE-like elements also bind
hnRNP A2. These experiments led to the identification of an
11-base subsequence of the A2RE that bound to hnRNP A2 as
strongly as the A2RE and to the observation that many single
nucleotide changes within this sequence greatly diminished
this interaction. The strength of the RNA-hnRNP A2 interac-
tion was directly correlated with the efficiency of cytoplasmic
RNA transport in oligodendrocytes. Antisense oligonucleotide
treatment of oligodendrocytes caused a reduction in hnRNP A2
levels and a concomitant decrease in cytoplasmic transport of
MBP RNA providing additional evidence for the involvement of
this protein in RNA transport. A2RE-like sequences from neu-
ronal mRNAs were shown to both bind hnRNP A2 and support
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cytoplasmic transport of RNA in oligodendrocytes, suggesting
that other mRNAs may also be transported by a mechanism
involving hnRNP A2.
EXPERIMENTAL PROCEDURES
Mutant Oligoribonucleotide Synthesis and Characterization—Oli-
goribonucleotides were obtained from Oligos Etc, Inc. (Wilsonville, OR).
All incorporated 3!-linked biotin to permit attachment to streptavidin-
conjugated superparamagnetic particles (Roche Molecular Biochemi-
cals). These oligoribonucleotides were purified by the supplier, but
further analysis was performed to establish that they contained no free
biotin and could bind equally to the magnetic particles. In most exper-
iments the magnetic particles were saturated with the biotinylated
RNA with the presence of excess, unbound RNA confirmed by agarose
gel electrophoresis of the supernatants. Significant variations in bioti-
nylation were also excluded by two other methods. First, dot blots of
equivalent amounts of RNA, as assessed by their absorbance at 260 nm,
were developed with streptavidin-conjugated alkaline phosphatase
(Sigma). Second, equal amounts of the biotinylated oligoribonucleotides
were added to equivalent aliquots of magnetic particles, and the excess
RNA was washed away. The particles were then treated with RNase-
free proteinase K to hydrolyze the streptavidin, and the released RNA
was purified by phenol-chloroform-isoamyl alcohol extraction, concen-
trated by vacuum centrifugation, and electrophoresed on a 4% agarose,
2.2 M formaldehyde gel. No significant variations in the amounts of the
ethidium bromide-stained RNAs were evident.
hnRNP A2 Isolation—Rat brain protein extracts were prepared as
described previously (26). Human hnRNP A2 was expressed in Esche-
richia coli BL21(DE3) by using a plasmid (based on pET-9c) kindly
supplied by Dr. A. Krainer (Cold Spring Harbor Laboratories). Trans-
formed cells were induced with isopropyl-!-D-thiogalactopyranoside,
harvested by centrifugation, and lysed in 50 mM Tris-HCl, pH 8, con-
taining 2 mM EDTA, 100 "g/ml lysozyme, and 0.1% Triton X-100. The
soluble fraction was dialyzed against Buffer A (50 mM Tris-HCl, pH 8.5,
0.2 mM EDTA, 5% w/v glycerol) before concentrating 10-fold by chro-
matography on DEAE-cellulose (Whatman, United Kingdom) and one
step elution with 0.5 M NaCl in the above buffer. The concentrated
solution was then loaded on a Sephacryl S-300 column (Amersham
Pharmacia Biotech). Fractions containing hnRNP A2 were purified
using a linear 10–50% acetonitrile gradient in 0.1% trifluoroacetic acid
on a C4 reverse-phase HPLC column (Vydac, Hesperia, CA). Isolated
hnRNP A2 was stored in low ionic strength solutions to avoid precipi-
tation. Oligoribonucleotide-labeled superparamagnetic particles were
used for isolation of RNA-binding proteins as described previously (26).
RNA Protein Cross-linking—Rat brain proteins to be used in UV
cross-linking experiments were removed from A2RE-linked magnetic
particles by incubation in 300 mM MgCl2 for 1 h at 4 °C. Eluted proteins
were dialyzed against 10 mM HEPES, pH 7.5, containing 40 mM NaCl
and 5% glycerol. Equimolar amounts of oligoribonucleotide, 32P-labeled
with T4 polynucleotide kinase (New England Biolabs, Beverly, MA),
and protein were mixed in binding buffer (10 mM Tris-HCl, pH 7.5,
containing 1 mM EDTA, 4% w/v gylcerol, 0.1% w/v Triton X-100, and 1
mM dithiothreitol) and incubated for 30 min on ice. The reaction mix-
tures were then irradiated with 250 mJ of 254-nm light in a Bio-Rad GS
Genelinker UV chamber. The samples were run on 12% SDS-polyacryl-
amide gels using standard methods. Competition experiments were
performed by preincubation with a 50-fold excess of unlabeled RNA for
20 min prior to the addition of 32P-labeled oligoribonucleotide.
Construction of Vectors and in Vitro Transcription—The plasmid
vector pNKT7 was obtained from Dr. S. Kwon, University of Connect-
icut Health Center. This vector contains the green fluorescent protein
(GFP) open reading frame under the control of the bacteriophage T7
promoter. SacI and XbaI sites allowed insertion of additional sequences
between the GFP open reading frame and the segment encoding the
poly(A) tail. The double-stranded inserts, which were synthesized on an
oligonucleotide synthesizer (Pacific Oligos, Lismore, Australia), in-
cluded the SacI and XbaI restriction sites on the ends of the 11- or
21-nucleotide segments incorporating the A2RE or A2RE-like se-
quences. The sequences of these inserts are in Fig. 1. E. coli were
transformed with these vectors, and the plasmids were isolated by
standard methods. All vectors were sequenced to ensure the integrity of
the inserted sequences.
Digoxigenin (dig)-labeled cRNA was generated as described previ-
ously (18). The purified plasmids were linearized with BSaW1 (New
England Biolabs), which cuts just 3! to the poly(A) tail, and used for in
vitro transcription in the presence of dig-labeled UTP (Roche Molecular
Biochemicals) with an Ampliscribe kit (Epicenter Technologies, Madi-
son, WI). The resultant RNAs were precipitated with 7.5 M ammonium
acetate; the pellet washed with 70% ethanol and then dissolved in
diethyl pyrocarbonate-treated water. They were further purified on
polyacrylamide gel matrix columns (Micro Bio-Spin Columns P-30 Tris,
RNase-Free; Bio-Rad) to remove any remaining free oligonucleotides
and salts, and an aliquot of each was subjected to electrophoresis on an
agarose-formaldehyde gel to verify purity and estimate the RNA
concentration.
RNA Microinjection and Visualization—Cultures of mouse oligoden-
droglia were produced from brains of newborn C57Bl/C6 mice as de-
scribed previously (18, 19, 27). Cells grown on coverslips were microin-
jected using an Eppendorf Micromanipulator (Eppendorf, Westbury,
NY) attached to a Zeiss Axiophot inverted microscope (Carl Zeiss,
Oberkochen, Germany) using phase contrast optics. The RNA was
mixed with Texas Red-conjugated dextran (10 kDa), filtered through a
0.2 "m spin filter (Millipore, Bedford, MA), and introduced into cells
using microinjection needles produced in a Flaming Brown micropi-
pette puller (Sutter Instruments, San Raphael, CA). Only relatively
large oligodendrocytes with well developed processes were injected.
After injection, coverslips were incubated at 37 °C for 30 min to allow
peripheral transport to occur.
The cells were washed in PIPES-buffered saline (PIBS) at pH 7.0
(120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 25 mM D-glucose,
and 20 mM PIPES) and then fixed for 20 min in 3.7% paraformaldehyde
(Sigma) in PIBS. After washing with PIBS, the cells were permeabilized
by incubation for 2 min in 0.1% Nonidet P-40 (Sigma) diluted in the
same buffer, washed, and then incubated in 5% goat serum in PIBS for
10 min. To visualize dig-labeled RNA, the cells were incubated for 1–2
h in the primary antibody (mouse anti-digoxin; Jackson ImmunoRe-
search Laboratories, Inc., West Grove, PA), washed extensively, incu-
bated in secondary antibody (fluorescein isothiocyanate-conjugated
goat anti-mouse IgG; Jackson ImmunoResearch Laboratories) for 1–16
h, and washed with PIBS. Finally, 70% glycerol containing an anti-
fading agent (1,4-diazabicyclo[2,2,2]octane) was added to the cells be-
fore they were viewed on a Zeiss Axioscope fluorescence microscope and
imaged using a Zeiss LSM 410 confocal microscope equipped with a "
63 (1.4 numerical aperture) lens. All injected cells that survived the
subsequent treatment, as judged by the presence of the labeled dextran,
were imaged to permit the comparison of the distribution of dextran and
fluorescein isothiocyanate-labeled exogenous RNA. The imaged cells,
typically 30 or more for each RNA, were scored as positive or negative
for transport by three independent observers using well established
criteria (18, 25).
Antisense Treatment of Oligodendrocytes—Cultures of mouse oligo-
dendrocytes were incubated for 18 h in defined culture medium (28)
that contained a final concentration of 8 "M phosphorothioate oligonu-
cleotide directed against the translation start site of hnRNP A2 (20).
Although hnRNP A1 and A2 share considerable sequence similarities,
there is little within this domain. The antisense sequence used for these
experiments, CTTTTCTCTCTCCATCGCGGA, was synthesized by the
Molecular Core Facility at the University of Connecticut Health Center.
In control experiments, the corresponding sense oligonucleotide (in-
verse complement) was used. Following oligonucleotide treatment, the
hnRNP A2 levels in the cells were examined by electroblotting and
immunofluorescence microscopy, and microinjection experiments were
used to study transport of MBP RNA (see above). For electroblotting,
approximately equal numbers of cells were used. The blots were devel-
oped with a mouse antibody to hnRNP A2 (a gift from Dr. William
Rigby, Dartmouth; used at a dilution of 1:1000) and rabbit polyclonal
antibody to the 65-kDa ribophorin I (a gift from Dr.Gert Kreibich, New
York University; used at a 1:1000 dilution) (29) as a control for protein
loading followed by horseradish peroxidase-conjugated secondary anti-
bodies. For confocal microscopy the cells were fixed and treated with the
above antibody to hnRNP A2, followed by a fluorescein isothiocyanate-
conjugated goat anti-mouse IgG secondary antibody (Jackson Immu-
noResearch Laboratories).
RESULTS
An 11-Nucleotide A2RE Subfragment Binds hnRNP A2—
Previous experiments have shown that in the presence of hep-
arin A2RE binds to a small group of rat brain proteins, includ-
ing predominantly hnRNP A2 and two isoforms of hnRNP A3
(26). The A2RE sequence is comprised of three imperfect, over-
lapping tandem repeats (Fig. 1). Our first objective in the
experiments reported here was therefore to establish whether
the entire 21-nucleotide A2RE was required for this association
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or if a subsection would suffice.
Three 11-nucleotide fragments were synthesized comprising
the 5!- and 3!-halves and the middle of the A2RE (Fig. 1). To
facilitate comparison between these oligoribonucleotides, iden-
tical amounts of magnetic particles were added to an excess of
the biotin-labeled RNAs ensuring saturation of the streptavi-
din binding sites. Saturation was verified by showing that
there was free oligonucleotide in the supernatant after removal
of the particles and that use of higher RNA concentrations
resulted in no increase in the binding of hnRNPs A2 and A3, as
measured by Coomassie Blue staining of SDS-polyacrylamide
gels. It was further established, by reverse-phase HPLC, that
the synthesized oligoribonucleotides contained no free biotin
that could have caused variable amounts of RNA to be bound to
the particles.
When bound to the magnetic particles each of these oligori-
bonucleotides bound hnRNP A2 in rat brain extracts; the bind-
ing was strongest for the 5!-segment (A2RE11) and lowest for
the middle segment (Fig. 2), reflecting the base differences in
the 3!- and middle 11-nucleotide segments and particularly the
absence of three 3!-nucleotides in the latter. The A2RE11 re-
producibly bound hnRNP A2 a little stronger than the full-
length A2RE and might thus also be expected to act as an RNA
transport signal if association with this protein is a prerequi-
site for transport. No direct attempt was made to determine if
a still shorter oligoribonucleotide would bind as well as the
A2RE, but as mutations at or close to the ends of this segment
diminish binding to the protein, most, if not all, of the A2RE11
appears to be needed.
The binding of the two hnRNP A3 polypeptides to the A2RE
fragments and to mutant A2RE sequences discussed below
paralleled that of hnRNP A2, reinforcing the view that these
proteins together form a complex with the RNA. In the discus-
sion below we have, however, focused our attention on hnRNP
A2 because earlier studies showed that isolated hnRNP A2, but
not A3, associated directly with the A2RE (26).
A2RE11 Mutations Reduce hnRNP A2 Binding—The se-
quence requirements for binding to hnRNP A2 have been fur-
ther explored by following the effects of single nucleotide
changes within the A2RE11. The initial nucleotides targeted
were those conserved in the A2RE-like sequences from several
different transported RNAs (see below), and the later targets
were the poorly conserved nucleotides in these sequences (Fig.
1). For the conserved residues the modifications introduced
were transitions (i.e. purine to purine or pyrimidine to pyrim-
idine) as their conservation suggested that these mutations
might not be well tolerated, whereas the latter were subject to
the less conservative transversions (purine to pyrimidine and
vice versa). These modified 3!-biotin-conjugated oligoribonucle-
otides were attached, through the biotin-streptavidin interac-
tion, to magnetic particles, which were then added to rat brain
protein extracts as described in the previous section.
The effects of base substitutions on hnRNP A2 binding var-
ied markedly from one position to another. Seven transitional
mutants all diminished hnRNP A2 and A3 binding, but
whereas transitions in positions 1, 2, 7, 10, or 11 still had
detectable hnRNP A2 binding, transitions at positions 8 and 9
had little or no detectable hnRNP A2 binding (Fig. 3A). Simi-
larly, transversion of position 3 had very little effect on hnRNP
A2 binding, but transversions at positions 4 and particularly 5
and 6 markedly diminished hnRNP A2 binding (Fig. 3B).
Mutations Interfere with RNA Transport—The A2RE,
A2RE11, and several of the mutant sequences that showed
little binding in the magnetic particle experiments were in-
serted in the 3!-untranslated region of DNA encoding GFP. The
RNAs were transcribed in vitro in the presence of dig-conju-
gated UTP to facilitate detection in fixed cells, purified, and
then microinjected into the soma of mature, cultured oligoden-
drocytes, together with Texas Red-labeled, 10-kDa dextran.
The dextran spreads uniformly through the cell, and the fluo-
rescence associated with it allows identification of injected cells
and visualization of their processes. Laser scanning confocal
micrographs of typical transporting and nontransporting cells
are shown in Fig. 4.
Previous studies using this assay have revealed that RNAs
containing the A2RE are transported in more than 70% of
injected cells (25). Conversely, RNAs lacking the A2RE are
transported in less than 15% of injected cells (25). Thus, the
dynamic range of the microinjection assay is from 15 to 70%.
RNA containing A2RE11 was transported as efficiently as RNA
containing the complete A2RE, indicating that the A2RE11 is
sufficient to mediate RNA transport (Fig. 5). RNAs containing
the mutations G6C, A8G, and G9A (Fig. 1) were transported at
levels comparable to RNAs lacking a recognizable transport
sequence. Thus, there is a direct correlation between hnRNP
A2 binding and cytoplasmic transport.
Using a previously described antisense method (20), we un-
dertook to inhibit hnRNP A2 translation in oligodendrocytes
and examine their capacity to transport microinjected MBP
RNA. Western blot analysis indicated that antisense oligonu-
cleotide treatment reduced hnRNP A2 levels to approximately
50% of untreated control cultures (Fig. 6F, results from five
experiments), with a corresponding reduction in hnRNP A2
immunostaining. A small decline (#15%) was also consistently
observed in hnRNP A2 levels in oligodendrocyte cultures
treated with sense oligonucleotides.
Although untreated cells typically transported microinjected
RNA into the peripheral myelinating processes, treatment with
phosphorothioate-modified oligonucleotides complementary to
the translation start site of hnRNP A2 changed the RNA dis-
tribution. Typically, RNA immunofluorescence was restricted
to the cell body and proximal cytoplasmic trunks (Fig. 6, A and
B) with few granules detected in the distal cytoplasmic web.
Although not transported, the microinjected RNAs were con-
centrated into granular aggregates (Fig. 6, B and C). Of those
antisense-treated cells that did transport RNA, the granules
appeared less abundant than in either untreated or sense oli-
gonucleotide-treated control cells.
Control cultures were treated with the corresponding sense
oligonucleotide and appeared indistinguishable from untreated
cultures. In most injected cells, RNA granules were observed in
FIG. 1. Sequences of oligoribonucleotides used in these exper-
iments. Bases that differ from those in the A2RE are in bold and
underlined. Mutations were introduced at each nucleotide in A2RE11
as transversions (C3G, A4C, A5C, G6C) or transitions (G1A, C2U, G7A,
A8G, G9A, C10U, C11U). GABAR(A), #-amino butyric acid receptor $
subunit. The nonspecific sequence (NS) has the same overall composi-
tion as A2RE.
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both major and minor cytoplasmic trunks and scattered within
the membrane sheets extending from these processes (Fig. 6, D
and E). Several other control oligonucleotides used under the
same conditions have produced similar results (20). As re-
ported previously for untreated cells, approximately 20% ex-
hibited only perinuclear staining (25).
Counts were made of the number of cells which had trans-
ported the labeled RNAs after oligonucleotide treatment. As
depicted in Fig. 6G, antisense treatment reduced the percent-
age of transporting oligodendrocytes compared with sense-
treated cultures. When cultures were fixed, stained for MBP,
and their relative sizes compared by phase microscopy and
MBP immunofluorescence, there were no statistically signifi-
cant differences observed in cell sizes and no qualitative differ-
ences in cell appearance that would distinguish between the
different treatments.
Other A2RE-like Sequences Bind hnRNP A2—Other local-
ized mRNAs contain A2RE-like sequences (25), raising the
possibility that these RNAs are transported by the same path-
ways as MBP mRNA in oligodendrocytes. Evidence for this
hypothesis comes from the observation that MAP2A mRNA
including the A2RE-like region is localized, whereas splicing
variants lacking this sequence are not (25, 30). It was therefore
of particular interest to see if A2RE-like sequences from other
RNAs could also bind to hnRNP A2. Oligoribonucleotides with
the A2RE-like sequences from the neural proteins MAP2A,
#-amino butyric acid receptor $ subunit, activity-related cy-
toskeleton-associated protein (ARC), and myelin-associated/ol-
igodendrocyte basic protein (MOBP81A) were synthesized as
3!-biotin conjugates for attachment through streptavidin to
magnetic particles. Oligonucleotides were end-labeled with 32P
for detection on SDS-polyacrylamide gels following UV cross-
linking in the presence of recombinant human hnRNP A2 or
the affinity-purified A2RE-binding proteins from rat brain.
The A2RE was readily cross-linked to purified, recombinant
hnRNP A2 (Fig. 7A). Another oligoribonucleotide with random-
ized sequence (nonspecific sequence 1 of Hoek et al. (26)) was
also cross-linked at about half the level of the A2RE (Fig. 7B).
This is consistent with biosensor data showing that, in the
absence of heparin, this protein possesses two oligonucleotide
binding sites, one of which is nonspecific and one is specific for
the A2RE. When added to protein extracts of rat brain, UV
cross-linked, and run on SDS-polyacrylamide gels and autora-
diographed, the radiolabeled A2RE comigrated with radiola-
beled A2RE cross-linked to recombinant human hnRNP A2.
Oligoribonucleotides with A2RE-like sequences from other lo-
calized messages also cross-linked to rat brain hnRNP A2. The
A2RE-like sequences from ARC, #-amino butyric acid receptor
$ subunit, and MAP2A bound as well as the A2RE, but
MOBP81A bound less strongly. No cross-linking of nonspecific
RNA to the rat brain hnRNPs A2 and A3 was observed, in
contrast to the binding to recombinant hnRNP A2; this sug-
gests that when a complex is formed with hnRNP A2 and the
two hnRNP A3 isoforms the nonspecific site may be occluded
leaving only the specific site available for RNA binding. It is
also possible that hnRNP A2 purified from rat brain is post-
translationally modified in a way that diminishes binding of
RNA to the nonspecific site.
Addition of a 50-fold excess of nonspecific oligoribonucleotide
prior to UV irradiation diminished binding as anticipated be-
cause one of the two sites on the protein binds RNA nonspe-
cifically. A similar excess of the A2RE eliminated binding of the
radiolabeled RNA (data not shown). Association of neural
A2RE-like sequences with hnRNP A2 was confirmed by isola-
tion of this protein from rat brain extracts with magnetic par-
ticles bearing these oligoribonucleotides. Again, MAP2A and
ARC oligoribonucleotides bound at least as well as A2RE, but
the #-amino butyric acid receptor $ subunit, and particularly
MOBP81A, bound more weakly (Fig. 7B).
Other A2RE-like Sequences Support Transport—As dis-
cussed above, UV cross-linking/gel retardation and magnetic
particle binding experiments have shown that oligoribonucle-
otides with the base sequences of several of these potential
transport signals bind strongly to hnRNP A2. We therefore
investigated whether these sequences could also confer trans-
portability on GFP message. The results presented in Fig. 5
FIG. 2. Deletion analysis of A2RE binding to hnRNP A2. Magnetic particles bearing the biotinylated sequences A2RE, A2RE11, A2RE3!,
A2REmid, a randomized nonspecific sequence (NS), or no RNA were used to isolate proteins from rat brain extracts. Bound proteins were removed
for analysis on Coomassie Blue-stained SDS-polyacrylamide gels. The position of hnRNP A2 (36 kDa) is shown (arrowhead). The two bands
immediately above hnRNP A2 have been identified by protein sequencing as isoforms of hnRNP A3 (K. S. Hoek and R. Smith, unpublished data).
FIG. 3. Mutational analysis of A2RE binding to hnRNP A2. 3!-biotinylated oligoribonucleotides were synthesized with mutated sequences
and used in magnetic particle experiments; bound proteins were removed and analyzed by electrophoresis as described previously. Unlabeled
magnetic particles and magnetic particles labeled with a randomized nonspecific sequence were used as controls. The position of hnRNP A2 is
shown (arrowhead). A, the effect of transitional mutations introduced at positions 1, 2, 7, 8, 9, 10, and 11 on hnRNP A2 binding. B, the effect of
transversional mutations introduced at positions 3, 4, 5, and 6 on hnRNP A2 binding. NS, nonspecific sequence.
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show that a chimera containing the MAP2A A2RE-like se-
quence inserted into GFP RNA promoted RNA transport in
cultured oligodendrocytes as effectively as the A2RE or
A2RE11. MOBP81A was less effective in promoting transport;
about 40% of the cells transported this RNA. This is greater
than the 15% that transport the GFP message lacking a trans-
port signal yet below the 75–80% that transport RNAs contain-
ing the A2RE from MBP mRNA. Taken together with the
binding studies referred to above, these data indicate that the
MOBP81A A2RE-like sequence is relatively less effective in
interacting with hnRNP A2 and this results in compromised
cytoplasmic transport.
DISCUSSION
hnRNP A2 is a component of the nuclear hnRNP core parti-
cles that package nascent pre-mRNA presumably without re-
gard for nucleotide sequence (31). But hnRNP A2 is also capa-
ble of binding to specific DNA and RNA sequences, including
the telomeric sequence (32–34) and the A2RE (26). As shown
previously (26), nonspecific binding is eliminated by the addi-
tion of heparin, whereas it reduces but does not abrogate asso-
ciation of hnRNP A2 with the A2RE. This observation has been
confirmed by our recent resonant mirror biosensor studies,
which have shown that the protein possesses one nonspecific
oligoribonucleotide binding site and another that is selective
for the A2RE and cognate sequences.4 Our mutational analysis
highlights the specificity of the A2RE interaction with hnRNP
A2; some single nucleotide changes have no effect, whereas
others eliminate this interaction. Thus, hnRNP A2 binds the
A2REs bearing the C2U, C3G, and C10U mutations almost as
strongly as the native A2RE but not those with the mutations
A5C, G6C, A8G, and G9A.
Although the earlier deletion analysis (25) showed that the
21-nucleotide A2RE is sufficient and necessary for mRNA cy-
toplasmic trafficking, our experiments demonstrate that a sub-
fragment, the 5! 11 nucleotides, can both bind to hnRNP A2
and confer transportability on an RNA that is not otherwise
transported. Examination of the A2RE and the A2RE-like se-
quences of other localized mRNAs (25) also reveals tandem,
overlapping sequences that have high sequence identity. So, for
example, the 5!-half of the A2RE has the sequence GCCAAG-
GAGCC; overlapping by one nucleotide with this segment is the
3!-sequence CAGAGAGCAUG, in which the common nucleo-
tides have been underlined. The mutations G1A and C2U di-
minished the protein binding but had far less effect than mu-
tations in many other positions, suggesting that the core
recognized by the protein may be CAAGGAGC. But some var-
iation within this segment is tolerated as illustrated by the
corresponding regions, CAAGGAGU and UGAGGAGG, of the
MAP2A and ARC RNAs, respectively, which bind hnRNP A2 at
least as strongly as the A2RE. The AGGAG sequence is con-
served in all of the oligoribonucleotides in Fig. 1 that bind
4 J. Shan, K. S. Hoek, G. J. Kidd, T. P. Munro, D. J. Winzor, D. R.
Hall, A. Schindeler, and R. Smith, submitted for publication.
FIG. 4. Confocal laser scanning microscope images of four rep-
resentative mouse oligodendrocytes. Cells were microinjected with
dig-labeled RNA and immunofluorescently labeled with both anti-
digoxin monoclonal antibodies (B, D, F, and H) to highlight the position
of injected RNA within the cell and 10-kDa Texas Red-labeled dextran
(A, C, E, and G) to show cell morphology. A and B and C and D show
cells injected with RNA containing mutated A2RE11 (C3G and A8G,
respectively); the injected RNA is largely confined to the cell body with
minimal RNA transport into the processes. E and F and G and H show
cells injected with RNA containing the MAP2A A2RE-like sequence and
A2RE, respectively, exhibiting significant transport of the RNA into the
processes. Scale bars, 25 "m.
FIG. 5. Transport of heterologous RNAs in mouse oligodendro-
cytes. The proportion of cells that transported RNA is shown for RNAs
containing the indicated oligoribonucleotides inserted in the GFP open
reading frame (ORF). A2RE and A2RE11 facilitate RNA cytoplasmic
transport of GFP RNA, whereas RNAs containing the mutated A2RE11
sequences exhibit message transport only slightly above the levels of
GFP cRNA, which lacks a transport sequence. The A2RE-like sequence
in MAP2A was sufficient to promote transport, whereas the proportion
of cells positive for transport was significantly reduced for the corre-
sponding sequence from MOBP81A mRNA. For each construct at least
30 cells were scored as positive or negative for RNA transport. The error
bars show the statistical standard deviations.
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strongly to hnRNP A2 (with the exception of the G7A mutant,
which binds, albeit less strongly than the A2RE) and is modi-
fied in all those that show markedly lower binding.
Despite this sequence repetition, deletion of the 3! 10 nucle-
otides of the A2RE does not lower the RNA binding to hnRNP
A2; A2RE11 binds as tightly as the whole A2RE. This obser-
vation reinforces the view that the footprint of the RNA on the
protein arises from a segment of 6–8 nucleotides. This associ-
ation could, however, still be modulated by interactions with
nucleotides outside this core.
Although our earlier studies (26) had demonstrated a strong
and sequence-specific interaction between hnRNP A2 and the
A2RE, a sequence known to be necessary for cytoplasmic RNA
trafficking, no direct link was established between this inter-
action and RNA transport. This link is provided by the RNA
transport experiments reported here. RNA segments that bind
strongly to hnRNP A2, A2RE, A2RE11, and the cognate
MAP2A sequence, when attached to GFP RNA result in effi-
cient transport into the processes of oligodendrocytes. By con-
trast, oligoribonucleotides such as G6C, A8G, and G9A, which
show little or no interaction with hnRNP A2, do not support
GFP RNA transport.
Treatment of cultured oligodendrocytes with antisense, but
not sense, oligoribonucleotides directed against the hnRNP A2
translational start site causes a moderate, reproducible reduc-
tion of the concentration of hnRNP A2. There is a concomitant
decrease in MBP RNA transport, providing further evidence
that A2RE-mediated transport is hnRNP A2-dependent. Al-
though some artifacts are possible with antisense protocols
(35), they predominantly involve sense effects or nonspecific
effects of exposure to oligonucleotides. At the concentrations
used here, treatment with the sense oligonucleotide had no
detectable effect on RNA transport, and neither oligonucleotide
had obvious toxicity affecting myelin membrane morphology or
oligodendrocyte size.
The existence of high cytoplasmic concentrations of hnRNP
A2 in some neurons suggests that these cells may use a path-
FIG. 6. Effects of antisense oligonu-
cleotide treatment on MBP RNA
transport. A–C, antisense-treated cells.
A, RNA staining is primarily restricted to
the perinuclear cytoplasm with only one
or two spots of staining away from the cell
body (arrowhead). Background fluores-
cence is enhanced here to show cell out-
line; the asterisk indicates adjacent, unin-
jected cell. N, nucleus. B, higher
magnification image; C, in an image of a
second treated cell, perinuclear RNA
staining is granular. D and E, sense-
treated control cell. Microinjected RNA is
detected in the perinuclear and periph-
eral cytoplasm; E, at higher magnifica-
tion, RNA granules are present in both
large and small processes. F, Western blot
of hnRNP A2 levels (36-kDa band) in
sense (s) and antisense (a) oligonucleoti-
de-treated cells. G, histogram showing
the proportion of oligodendrocytes trans-
porting microinjected MBP RNA after
treatment with antisense, sense, and no
oligonucleotides. Cells were scored as
transporting by comparison with A and D.
Only intact cells showing significant
staining were counted. Values are mean
and S.E. for six experiments (antisense,
148 cells total), five experiments (sense,
89 cells total), and one experiment (un-
treated control, 63 cells; similar control
values were previously reported by
Ainger et al. (18)). Scale bars in A and D,
20 "m; B, C, and E, 2 "m.
FIG. 7. Other A2RE-like sequences bind hnRNP A2. A, radiola-
beled RNA probes (Fig. 1) were incubated with purified recombinant
human hnRNP A2 or A2RE-binding proteins purified from rat brain
and UV cross-linked prior to analysis by SDS-polyacrylamide gel elec-
trophoresis and autoradiography. The resulting RNA-protein com-
plexes are shown (arrowhead). B, biotinylated RNA probes (Fig. 1) were
used in a magnetic particle experiment. RNA-bound proteins were
removed and analyzed by electrophoresis as above (Fig. 2). Beads la-
beled with nonspecific sequence (NS) were used as a control. The
position of hnRNP A2 is shown (arrowhead).
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way for RNA transport which parallels that in oligodendro-
cytes. This possibility is reinforced by the presence in neurons
of several mRNAs that are known to be localized (12, 14, 17,
36–40). Several of these localized messages contain A2RE-like
sequences, which we have shown bind as efficaciously to
hnRNP A2 as the A2RE (Fig. 7). Additionally, our studies of the
transport of RNA containing the ARC and MOBP81A A2RE-
like sequences support the conclusion, drawn from the above
studies of the A2RE11 mutants, that there is a direct correla-
tion between transport and hnRNP A2 binding. Confirmation
of the involvement of these mRNAs in an hnRNP A2-mediated
transport in neurons will require direct observations on these
cells.
An hnRNP-based transport system may also operate for
other messages, such as that for protamine 2 in testis, and for
viral messages (25). Several viral mRNAs contain A2RE-like
sequences, and our preliminary studies indicate that some,
including those from HIV vpr and gag genes, bind to hnRNP A2
as efficiently as the A2RE and mediate RNA transport in
oligodendrocytes.
In summary, hnRNP A2 may have multiple roles in RNA
processing and trafficking. In the nucleus it is a component of
core particles that bind pre-mRNA, whereas in the cytoplasm it
plays a role in transport of some localized mRNAs as indicated
by the following evidence: (i) hnRNP A2 binds specifically to
the segment of MBP mRNA that is necessary and sufficient for
cytoplasmic transport in oligodendrocytes; (ii) modifications of
this A2RE that abrogate hnRNP A2 binding also interfere with
RNA transport; (iii) exogenous A2RE-containing RNA injected
into oligodendrocytes colocalizes with hnRNP A2 in cytoplas-
mic granules; (iv) reduction of hnRNP A2 levels in oligodendro-
cytes by treatment with antisense, but not sense, oligoribo-
nucleotides interferes with transport of A2RE-containing RNA;
(v) hnRNP A2 binds A2RE-like sequences in other localized
messages; and (vi) hnRNP A2 is abundant in the cytoplasm of
many brain cells in which mRNAs are known to be localized.
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